| Names | |
|---|---|
| Preferred IUPAC name | (2S)-2-aminopropanoic acid |
| Other names | 2-Aminopropanoic acid DL-Alanine Ala |
| Pronunciation | /ˌɛl.əˈlæ.nin/ |
| Identifiers | |
| CAS Number | 56-41-7 |
| 3D model (JSmol) | `3DModel: JSmol "CC(C(=O)O)N"` |
| Beilstein Reference | 635 |
| ChEBI | CHEBI:16977 |
| ChEMBL | CHEMBL598 |
| ChemSpider | 595 |
| DrugBank | DB00160 |
| ECHA InfoCard | ECHA InfoCard: 100.003.487 |
| EC Number | 2.6.1.2 |
| Gmelin Reference | 6357 |
| KEGG | C00041 |
| MeSH | D000686 |
| PubChem CID | 5950 |
| RTECS number | AY2990000 |
| UNII | YFS201402R |
| UN number | UN3335 |
| Properties | |
| Chemical formula | C3H7NO2 |
| Molar mass | 89.09 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | D = 1.432 g/cm3 |
| Solubility in water | 166 g/L (25 °C) |
| log P | -2.85 |
| Vapor pressure | <0.01 hPa (20°C) |
| Acidity (pKa) | 2.34 |
| Basicity (pKb) | pKb = 3.72 |
| Magnetic susceptibility (χ) | -9.6×10⁻⁶ |
| Refractive index (nD) | 1.498 |
| Dipole moment | 1.35 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 86.13 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -528.0 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -1507.5 kJ/mol |
| Pharmacology | |
| ATC code | A16AA10 |
| Hazards | |
| Main hazards | Not hazardous. |
| GHS labelling | GHS07: Exclamation mark |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | No hazard statement. |
| Precautionary statements | P261, P264, P270, P272, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P330, P362+P364, P501 |
| NFPA 704 (fire diamond) | 1-0-0-🛇 |
| Flash point | 93 °C |
| Lethal dose or concentration | LD50 oral rat 15000 mg/kg |
| LD50 (median dose) | LD50 (median dose): Oral, rat: 15000 mg/kg |
| NIOSH | SR4025000 |
| PEL (Permissible) | 15 mg/m³ |
| REL (Recommended) | 10 g |
| Related compounds | |
| Related compounds | D-Alanine Beta-Alanine Glycine Serine |
| Product Identification | Description | Manufacturer Technical Notes |
|---|---|---|
| Product Name | L-Alanine | The designation “L-” refers to the levo isomer. L-alanine is consistently specified in biomolecule manufacturing and nutritional chemistry. D- and DL- forms differ by production process and downstream use. |
| IUPAC Name | (S)-2-aminopropanoic acid | This nomenclature follows IUPAC rules for amino acid stereochemistry. Correct assignment is verified by chiral HPLC or optical rotation, following the requirements for biological activity. |
| Chemical Formula | C3H7NO2 | Batch formulas are confirmed post-synthesis by elemental analysis and mass spectrometry as required by analytical protocols. Analytical tolerances can be grade-dependent. |
| Synonyms & Trade Names | 2-Aminopropanoic acid, α-aminopropionic acid | Alternative names trace back to historical and regional naming conventions adopted by industry and regulatory authorities. Actual labeling on packaging follows end-market regulations and batch documentation. |
| CAS Number | 56-41-7 | The CAS Registry Number uniquely identifies L-alanine in substance indexing and regulatory filings. Custom documentation for export and import consistently references this identifier. |
| HS Code & Customs Classification | 2922.49 | This HS code covers amino acids bearing more than one kind of oxygen function. Actual tariff code allocation can require supporting documentation, especially for shipments with specific grade claims or blended forms. Local regulators or customs authorities may request additional composition analysis to confirm classification. |
Raw material selection for L-alanine starts with validated starting amino acid sources or pyruvate for fermentative routes. Route selection hinges on end-use requirements: medical and food grades often require fermentation or enzymatic resolution, while technical grades may use racemic chemical synthesis. Process route selection impacts cost, traceability, and residual impurity profiles.
Key control points during production focus on enantiomeric purity and mitigation of by-products such as D-alanine, which may arise from incomplete resolution or racemization during downstream processing. High-purity grades undergo additional purification steps like crystallization, activated carbon decolorization, and recrystallization. In-process monitoring relies on HPLC or chiral chromatography for stereochemical analysis. Batch consistency is maintained by strict monitoring of reaction conditions, purification batch cuts, and yield tracking by analytical reconciliation.
Release criteria, whether for bulk export or customer-specific packing, are tailored by application. Nutritional, pharmaceutical, and food applications require control of residual solvent, chiral purity, and trace heavy metals. Technical and feed grades may set different limits based on regional standards and downstream usage. Documentation for compliance and regulatory inspection accompanies each batch, referencing both CAS and HS identifiers.
In our production environments, L-Alanine is typically received and processed as a crystalline powder. For most pharma, food, and industrial grades, the product presents as a white, odorless solid. The actual visual aspect may show minor variations from batch to batch, subject to differences in drying efficiency, crystallization rate, and source of raw materials, but significant color shifts are considered a deviation and are grounds for internal investigation. Melting point determination is part of standard batch release for food and pharmaceutical grades, but exact values depend on crystalline habit and purity. Boiling point is rarely relevant for practical handling—L-Alanine decomposes before reaching a true boiling state.
Density readings are primarily referenced during process design; variations due to compaction, particle size, and moisture content arise with bulk handling. The powder form simplifies blending and dissolution for downstream formulation, but hygroscopicity must be considered in humid climates or open transfer systems.
L-Alanine remains chemically robust under ambient conditions used in industrial and laboratory settings. It does not react with atmospheric oxygen at room temperature and is not prone to spontaneous polymerization, but trace metallic contaminants can catalyze discoloration during prolonged exposure to elevated temperatures or oxidative environments. Handling protocols adjust according to the grade's end use, especially where ultra-high purity is specified.
The compound dissolves readily in water, with solubility dependent on temperature and solution pH. In plant-scale solution preparation, particle size and agitation efficiency are monitored to ensure proper dissolution rates. For injectables and other regulated markets, solution clarity and absence of undissolved particles form part of the critical quality attributes. The presence of insoluble particulate—often associated with foreign matter contamination—triggers corrective actions in both production and quality assurance.
We define specifications according to the target application—pharmaceutical, food, biotech, or industrial. Detailed specification tables, including assay, heavy metals, loss on drying, and microbial limits, are maintained per grade. The precise values and parameters reflect both regulatory requirements and customer negotiating terms. For food and pharma, stricter impurity thresholds and microbiological standards are set by pharmacopeial references or client-specific requests.
Common impurities include residual inorganic salts, related amino acids, and trace organic impurities from precursor amino acids. Impurity levels respond directly to the process route and purification system. Routinely, internal controls scrutinize heavy metal content, bioburden, and residual solvents. Any result beyond threshold triggers an in-depth batch review and corrective action or possible batch rejection, with release only upon review by senior quality control specialists.
Test protocols lean heavily on compendial methods—HPLC, NMR, ICP-MS, and classical wet methods. For specialty or customer-mandated grades, custom validation is completed against the target impurity profile. Analytical platforms are maintained to ensure method detection limits and reproducibility align with batch-to-batch precision requirements.
Raw materials must consistently meet predefined purity criteria, considering both performance and regulatory compliance. The L-Alanine process may use enzymatic conversion of protein hydrolysates, fermentation of glucose using genetically optimized strains, or traditional Strecker synthesis for some industrial markets. Raw material origin and traceability play a critical role in both compliance reviews and downstream demand for allergen-free, botanical, or non-GMO grade declarations.
Where biotechnological production is specified, glucose fermentation using a tailored microbial strain is favored, reducing reliance on hazardous chemicals and streamlining waste management. If the Strecker pathway is chosen (often for industrial or feed grades), amination of acetaldehyde with ammonia and hydrolysis of the resulting intermediate occur under strictly controlled pH and temperature. Decision factors for route selection include desired throughput, impurity levels, final grade, and cost structure.
At multiple points, in-process testing ensures completion of conversion steps, minimization of side reactions, and early detection of foreign contamination. Crystallization from aqueous solution remains a common step for removing soluble inorganic byproducts and securing the right polymorphic form. Process temperature, pH, and solvent composition are continually monitored and adjusted to restrict undesired byproduct formation. Ultra-filtration, carbon treatment, or ion-exchange purification are deployed in pharma and food lines, but may be bypassed in technical-grade batches.
Batch release follows a stringent set of quality attributes aligned with the intended use class. Each lot must pass identity, purity, impurity, and microbiological checks before shipment. Standard batch-to-batch consistency is maintained through statistical process control with additional hold points for critical raw materials and any processing deviation. Final approval rests with quality assurance teams, not production.
L-Alanine serves as a starting material in protected peptide synthesis and as a chiral auxiliary in asymmetric synthesis. In the laboratory and pilot scale, the amino and carboxyl groups offer reactive sites for esterification, amidation, or acylation. Catalysts, solvent choice, and temperature are chosen subject to the selectivity and downstream processing requirements; for chiral purity, enzymatic methods may be employed.
Reaction pathways generally require acidic or basic conditions, with temperatures adjusted for optimal conversion rates and impurity suppression. Catalyst selection is determined by desired selectivity—acid chlorides and carbodiimides for peptide bond formation, mild bases for salt formation. Equipment compatibility is essential; PTFE or glass-lined reactors safeguard product quality during scale-up.
L-Alanine enables the manufacture of N-protected derivatives, simple esters, or peptide building blocks intended for pharmaceutical intermediate markets. Utilities for specialty formulations—parenteral nutrition, sports nutrition—draw upon granulated, spray-dried, or micronized grades, each with distinct solubility and compressibility profiles tied directly to the manufacturing step and final application form.
Storage stability hinges on factors including temperature, ambient humidity, and light exposure. For pharmaceutical and high-spec food grades, typical practice dictates cool, dry, and dark storage—ideally in sealed, food-grade containers, under inert gas blanketing for ultra-sensitive applications. In humid environments, desiccant use and regular checks on container seals are critical.
Polyethylene and polypropylene drums or lined fiber containers are standard. Glass may be specified for laboratory and reference standards. Contact with metals, particularly in moist conditions, is avoided due to potential for trace contamination and off-spec interactions, especially when supplying for parenteral or injectable preparation.
Shelf life depends on both storage conditions and grade. Pharma and premium grades undergo periodic re-testing; off-odor, discoloration, or caking signal degradation, contamination, or packaging failure. Product showing clumping or visible foreign particulate is quarantined for assessment. Expiry dates are assigned based on real-time or accelerated stability data, adjusted per grade and customer mandate.
L-Alanine carries no major hazard classification under the GHS system for standard grades. Material is handled using routine laboratory and food plant hygiene standards. Dust management and localized extraction mitigate airborne particulate during weighing and blending operations.
In production, the predominant risks arise from potential dust generation, which may pose a respiratory irritant in high-concentration handling. Strict dust control, regular air quality monitoring, and use of PPE are enforced in blending, sifting, and filling operations. Hygiene protocols include prompt spill cleanup and maintenance of segregated tool sets for different grades to prevent cross-contamination.
Existing toxicological data does not indicate acute hazards at normal occupational exposure levels. Chronic ingestion studies, relevant in nutritional and pharmaceutical contexts, confirm physiological compatibility. Ongoing surveillance for new toxicity findings is part of our standard safety review.
No specific occupational exposure limits apply for standard L-Alanine, but inhalation and skin contact are minimized through engineered controls and training. In case of major spillage or accidental contact, workplace procedures dictate prompt cleanup using vacuum aspiration and thorough washing with water. Medical attention is mandated only if symptoms persist.
L-Alanine output strongly depends on demand from food, pharmaceutical, and feed sectors. Production scales vary between continuous multi-tonne batches and smaller customized lots driven by purity and regulatory requirements. Fermentation from glucose or enzymatic methods frequently serve as the selected industrial approach, with batch-to-batch consistency ensured through process monitoring at key control points. Availability hinges on forward contract holdings, annual turnarounds, and raw material security—controlled via supplier vetting and contingency stocks.
Lead times reflect plant load, grade, documentation, special testing, and packaging requirements. For standard purity, ex-warehouse dispatch typically meets a two- to four-week window, unless custom specifications or compliance audits are needed. Minimum order quantities fluctuate by packaging form and client-specific specifications but are often driven by single-lot batch yield or shipping efficiencies rather than standardized policy.
L-Alanine is shipped in drum, bag, or bulk formats. Packaging is grade-sensitive: pharmaceutical and food grades require inert liners and often need batch traceability, tamper seals, and serialized labeling conforming to customer audit standards. Secondary overpacking and palletization adjust to hazard, hygiene, and transportation protocols outlined in release contracts. Specialized packaging may be negotiated for sensitive or high-spec finished goods lines.
Shipping options correspond to destination, regulatory hurdles, and customer urgency. CFR, FOB, and DDP structures are set as per Incoterms-based negotiation, with packaging configuration detailed at order placement. Payment terms are a function of buyer credit, contract duration, and compliance history; irrevocable L/C, 30-60 day open account, and partial upfront models prevail in differing markets.
L-Alanine cost structure starts with feedstock procurement—primarily glucose or other carbohydrate sources—affecting not just direct variable cost, but also process yield. Fermentation-based routes incorporate enzyme or microbial system costs, nutrient media, and energy inputs that scale nonlinearly with local utility rates and yield efficiency. Notable cost drivers include feedstock price volatility, energy pricing swings, downstream purification media costs, regulatory upgrades for environmental controls, and periodic compliance retesting for updated food or pharma regulations.
Price variation emerges primarily from differences in grade and purity specification. Pharmaceutical or injectable grades demand higher impurity removal (residual solvents, endotoxins, trace metals) vs. technical or feed grades. Microbial endotoxin testing, validated cleaning protocols, and enhanced traceability layers increase conversion and QA/QC costs. Certification (USP/EP/JP, Food Chemical Codex, Halal/Kosher) requirements introduce added documentation, line clearance, and batch release complexity. Bulk packaging reduces per-kg cost through material and labor savings, while small-format, sterile or serialized packaging commands a significant upcharge.
Globally, L-Alanine demand tracks with trends in functional foods, infusion therapy components, and animal nutrition upgrades. Production capacity in China outruns other regions, driven by integrated sugar chemistry sites and favorable policy incentives for export-oriented fine chemicals. Capacity tightness arises during currency devaluation cycles, raw material supply shocks, or regulatory clampdowns.
Regional nuances affect both demand and supply. In the US and EU, stringent food and pharma regulations limit the number of compliant suppliers, increasing quality differential pricing. Japan often insists on unique documentation or process validation, adding to lead time and landed cost. Indian production scales up to serve domestic and regional demand, but relies on cost-driven process design, resulting in uneven final purity. China holds dominant low-cost production, but output remains exposed to export controls, environmental policy shifts, and domestic pricing interventions.
Volatility in feedstock pricing and evolving regulatory requirements are expected to drive price adjustments through 2026. Upward price shifts remain likely during periods of starch/glucose market tightening or whenever compliance costs increase (GMP, cross-contamination prevention, carbon emission restrictions). Price compression occasionally emerges when new capacity comes online or when competitive pressure lowers conversion margins for technical-grade product in feed or niche industrial markets. For high-purity applications, sustained price stability depends on raw material and certification cost management, as well as on consistency-driven demand from pharmaceutical and parenteral nutrition supply chains.
Analysis draws from published customs/ex-tariff data, quarterly producer statements (where available), in-market demand tracking for pharma and food sectors, and trade association circulars regarding chemical input supply chains. Plant tour information, in-process audit feedback, and regional regulatory review cycles also inform cost structure mapping.
In 2024, major Chinese producers reported output constraints due to scheduled maintenance and environmental regulatory upgrades impacting wastewater and gas emissions management. EU-based buyers in the food sector have accelerated alternate supplier qualification due to evolving GMO and allergen-batch certification requirements. Market consolidation continues, with several small-scale facilities shifting capacity to custom fermentation intermediates.
NSF, EU Food Contact, and updated USP standards continue to tighten permissible impurity levels and batch trace documentation for pharmaceutical and food ingredients. Revised US FDA guidance targets microbial contaminant control at the fermentation stage, increasing audit frequency for importers and manufacturers alike.
Manufacturers contend with compliance and commodity market-driven volatility through multi-tiered sourcing strategies, process automation investments, and expansion of third-party certification coverage. For export markets, batch-by-batch documentation and release procedures shift to electronic platforms to meet both speed and legal traceability requirements. Batch segmentation and flexible packaging lines help align output with shifting regional order profiles and evolving regulatory demands.
L-Alanine finds routine use across food, pharmaceutical, animal nutrition, biotechnology, and chemical synthesis industries. Formulators rely on its well-defined amino acid profile for protein-related applications, as a flavor enhancer, and as a precursor or building block in specialty synthesis. Nutritional supplement producers apply it in human and animal formulations because of its bioavailability. Chemical manufacturers utilize L-Alanine in enantioselective synthesis and derivatization protocols. Each sector demands distinct purity, regulatory, and physical requirements, shaping the practical grade selection process.
| Grade | Target Application | Key Technical Factors |
|---|---|---|
| Food Grade | Beverages, seasoning blends, nutritional fortification | Flavor profile, absence of off-odors, food additive compliance, heavy metals and microbial limit testing |
| Pharmaceutical Grade | Parenteral and oral preparations, infusion solutions | USP/EP/JP compliance, residual solvent profile, bioburden and endotoxin control, particulate specification, trace-level impurity documentation |
| Feed Grade | Animal nutrition formulations | Protein content accuracy, batch homogeneity, absence of veterinary-relevant cross-contaminants, presence of macro- and trace-minerals as per premix standards |
| Industrial Grade | Chemical synthesis, buffer preparations, technical reactions | Purity readout adapted to non-food, non-pharma requirements; control of process-related residuals per customer use, physical handling attributes |
Purity: Critical for pharmaceutical and food segments, as they stipulate strict pharmacopeial or food grade minimums and impurity ceilings. Industrial and feed applications might tolerate slightly broader ranges, defined during contract review or specification alignment.
Moisture Content: Affects stability and caking, with pharmaceutical and some food applications requesting tighter control. Grade selection influences drying step intensity.
Heavy Metals and Microbiology: Levels depend on application category and are driven by regulatory standards. In the plant, continuous monitoring during crystallization and drying limits cross-contamination in high sensitivity grades.
Physical Form: Sizing and flowability play a role in dispensing and mixing, especially for automated food or feed blending systems. Finer or more free-flowing variants are often preferred by bulk handlers.
Clarify the end-use: food additive, active pharmaceutical ingredient, animal feed ingredient, or synthetic intermediate. This step anchors all downstream technical and regulatory allocation of resources, starting with plant hygiene zoning and raw material pre-screening.
Determine if the target market follows US, EU, JP, or other regional standards. Pharmaceutical or food applications often trigger pharmacopeial or GRAS/food additive compliance processes, requiring documented traceability from incoming raw materials, through qualification batches, to full-scale runs.
Review the smallest acceptable impurity benchmark—not just for alanine itself but also for process-related secondary products, trace elements, and residual solvents. Feed and technical users sometimes accept lower purity or broader lot-to-lot specifications, but pharmaceutical and food end-users typically request analytical substantiation for each lot released.
Plant scheduling, packaging formats, and stockholding are affected by required annual volumes and fiscal constraints. Lower-volume, ultra-high-purity grades require campaign scheduling to avoid cross-contamination. Bulk users in feed or technical synthesis save costs with larger packs and standardized grades.
Before site-wide adoption, downstream users often run validation trials using representative lots. On the manufacturing side, this process helps identify potential issues in flowability, compatibility with customer processes, and perform stability checks under anticipated shipment and storage conditions.
Manufacturing of L-Alanine follows a robust quality system driven by formal external audits and internal oversight programs. Most production sites maintain recognized ISO 9001 quality management system certification, with regular recertification cycles and third-party surveillance. Certification scope covers all phases from raw material intake, intermediate storage, process control, to packaging and dispatch. Audit findings are tracked to closure, ensuring that critical control points are continually monitored and documented. GMP (Good Manufacturing Practices) adherence is prioritized for food-grade and pharmaceutical-grade product lines; this covers exclusion of cross-contaminants and rigorous hygiene protocols, verifiable by audit trails and inspection records.
Market applications drive the grade-specific certification profile. Food and pharmaceutical sectors require compliance with regulatory frameworks such as FSSC, HACCP, and in certain jurisdictions, specific registration with food and drug administration bodies. For veterinary and feed applications, manufacturing is validated according to feed standards and corresponding documentation (such as GMO-free status or feed additive dossiers) is available upon request. Halal and Kosher certificates, when relevant, reflect batch registration, ingredient traceability, and audit confirmation from respective certifying bodies, valid for the specified production period and clearly noted on batch documentation.
Each batch of L-Alanine is released against a Certificate of Analysis listing the tested parameters and release specification per customer contract or internal criteria. The actual certificate includes lot-specific analytical methods, reference standards used, and traceability from incoming raw material through final release. Non-standard analytical requests can be addressed through tailored testing agreements if driven by project- or market-specific needs. Full traceability reports follow the material from synthesis through packaging and distribution, aligned with regulated industry requirements for record retention and chain-of-custody control.
Consistent L-Alanine availability starts with stable core process capacity. Facilities are configured to support multi-shift operation with dedicated production lines for high-grade applications and parallel lines for industrial or technical requirements. Plant scheduling leverages forecast-driven and project-demand-driven algorithms, with surge capacity available through modular system expansion when demand spikes. Supply planners review contracted volumes, spot order trends, and forward-looking customer commitments on a rolling basis to minimize stock-outs and streamline lead times.
Production stability is anchored in aligning raw material buffers with actual process needs and by maintaining critical spares and backup utility systems. Output is monitored shift-by-shift, with real-time metrics tracking batch yields, process deviations, and key impurity markers. For customers with long-term demand, supply contracts can specify dedicated weekly or monthly tons, supported by production slot allocation and minimum stock guarantees at agreed inventory hubs or consignment models. For customers with variable or unpredictable demand, framework agreements set drawdown terms with periodic review for volume adjustment.
Technical teams handle sample requests by evaluating intended end use, required application data, and special test reports needed for validation or formulation studies. Standard product samples can be requested via digital channels with required compliance documents accompanying the dispatch. For customized needs or pilot studies (e.g., new food matrix, industrial polymer blends, pharmaceutical excipient screening), sales and R&D collaborate to define and supply representative samples from appropriate campaign lots, typically packaged with batch-specific certificates and any relevant regulatory paperwork.
Cooperation modes accommodate diverse supply chain structures. Long-term partners may prefer fixed-term supply contracts with quarterly volume true-ups, while innovation-driven projects often require phased deliveries or tiered quality reporting. Consignment stock at customer or regional warehouses allows for pull-based withdrawal against real-time consumption, reducing logistics delays and storage burdens. Custom labeling, packaging sizes, and integration into electronic procurement systems is available for multi-site customers seeking streamlined inbound flow. Support for import/export documentation and managed coordination with third-party auditors further simplifies compliance for customers operating in multiple jurisdictions or under sector-specific schemes.
In L-Alanine manufacturing, one focus area is developing higher yield enzymatic processes to limit by-product formation. Companies have been optimizing strain selection for fermentation routes, using raw materials with predictable conversion rates. Process engineers look for feedstock purity, reactor configuration, and real-time pH control strategies that avoid the generation of unwanted chiral isomers and minimize color body contamination in the crystallized product.
Recent studies have emphasized the metabolic engineering of microorganisms for more efficient substrate utilization, aiming to push productivity and simplify downstream purification. For synthetic processes, controlling stereo-selectivity and limiting racemization stands as a priority, particularly for pharmaceutical and injectable grades.
L-Alanine increasingly finds use in intravenous nutrition, as a food fortification amino acid, and in buffer formulations for bioprocessing. Application development teams work on fine-tuning purity and flow properties for high-density tablet compounding, beverage stability, and fermentation media use. Regional food regulations and pharmacopeial requirements also drive specification adjustments, prompting manufacturers to invest in in-line monitoring to support multi-market release.
During high-volume fermentation, exogenous contamination and pyrogen management require constant scrutiny. Strain drift can undercut yield consistency, so rigorous microbial banking and process validation are daily priorities. Chromatographic purification or membrane-based polishing steps are under evaluation for further reducing trace-level contaminants—this can impact final product grades available for parenteral versus food applications. Not every breakthrough leads to immediate adoption; scale-up instability, particularly in enzymatic vs. chemical routes, slows implementation. Quality control teams need to continuously evaluate batch-to-batch color and trace metal trends before batch release.
Demand projections show growth in medical and specialty food sectors, especially in North America and Asia-Pacific. Expansion in cell culture and fermentation media segments is expected to demand higher consistency in granular and crystalline product forms. Commodity grade and medical grade demand divergence will remain pronounced; capacity expansions are planned by several Asian manufacturers focusing on cost-effective bio-based routes.
Industrial L-Alanine production will move further toward renewable feedstocks and continuous processing to enhance economic and carbon efficiency. Digitalization of process control, including machine learning-supported predictive analytics, is set to reduce energy and wastewater footprints. Newer downstream technologies—especially continuous filtration and real-time impurity monitoring—will likely become plant standards for both conventional and next-generation routes.
Sourcing biomass-derived feedstocks links directly to sustainable manufacturing goals. Process engineers consider carbon intensity at the procurement stage, avoiding resource links to high-GHG or regionally unstable sources. Acid and salt consumption reduction in isolation and crystallization lines receives special attention to minimize effluent treatment. Increasing transparency over residual solvent, heavy metals, and water consumption remains a compliance priority, particularly in markets adopting new green chemistry assessment frameworks.
Direct support teams address application-specific questions, including solubility and compounding performance in particular customer processes. For injectable uses or specialty food applications, technical staff explain grade distinctions tied to trace metal, endotoxin, and microbial purity. Support also extends to on-site audits of customer blending or reformulation systems to help reduce process deviations linked to ingredient variability.
Customers shifting formulas or scale often need assistance with batch blending, feeding systems, or downstream solubility management. Application engineers review impurity profiles or physical forms (powder, granular, crystalline) and advise on equipment compatibility and moisture control measures to prevent caking or degradation during storage. Formulation chemists help adapt the supplied grade to local regulatory and functional requirements, especially when switching between regional pharmacopeial standards.
Full traceability of every batch supplied is maintained, with production records and analytical reports retained in line with internal and market-specific requirements. All feedback concerning shipment condition, certificate of analysis deviations, or application performance is logged and investigated by technical and quality teams. On request, extended technical data packages, retention samples, and impurity trace maps can be provided for regulatory or validation purposes. Staff receive training to update customers on significant process changes or supply chain developments that may impact product performance downstream.
We operate dedicated L-Alanine production lines designed for large-volume, continuous production. Our process control spans the entire chain, starting with fermentation inputs and ending at our on-site refining plant. Direct control over production parameters sharpens product consistency and batch traceability. Managing these stages under one roof provides confidence in final material quality and reliable output for contract manufacturing and formulated blends.
L-Alanine serves key roles across multiple industrial sectors. Food and beverage processors use it as a flavor enhancer and nutritional ingredient. Pharmaceutical processors require it for IV fluids, amino acid infusions, and clinical nutrition formulations. In the cosmetics and personal care space, steady purity impacts formulation stability for skin care products, shampoos, and cleansing agents. Feed and pet nutrition companies utilize it for amino acid balancing in compounded diets.
Precise process automation anchors our manufacturing approach. Every L-Alanine batch undergoes quantitative analytical testing in our in-house laboratories, backed by ISO-certified procedures. Rigorous tests for purity, microbial load, and heavy metals ensure compliance with application-specific requirements. Real-time process monitoring reduces variability and supports sustained supply programs. We maintain long-term retention samples and data archives, supporting backward traceability and ongoing compliance.
Efficient movement of L-Alanine from our site to client facilities depends on sturdy packaging and streamlined logistics. Each batch runs through dust-free handling environments and fills directly into poly-lined fiber drums, bulk bags, or custom containers sized for plant intake systems. Our packaging prevents moisture ingress and eliminates cross-contamination risk. Near-dock warehousing supports both container shipments and truck delivery, allowing agile response to changing demand or expedited restocking.
Our technical service engineers work directly with customer R&D, production, and procurement teams. Whether addressing formulation solubility, downstream process integration, or addressing regulatory documentation needs, our internal expertise draws on direct knowledge gained at our production site. We assist with scale-up planning and onsite process audits, ensuring performance expectations fit delivered material.
Direct access to L-Alanine from our site shortens procurement cycles and improves forecast alignment. Stable supply, accurate documentation, and technical transparency aid distributors and end manufacturers with reliability and predictable process planning. Cost control arises from integrated manufacturing, allowing contract buyers to lock in consistent quality and reduce variability in finished goods. Procurement teams benefit from historical performance and strong lot-to-lot consistency, supporting supply chain risk management and regulatory compliance efforts across industries.
In our daily production of L-Alanine, quality hinges on reliable assay and purity levels. We operate batch and continuous manufacturing lines dedicated to amino acid synthesis, so keeping a clear and measurable standard for every lot matters, particularly for customers in food, pharma, and biotech fields. The L-Alanine we bring to market walks out of our facility after stringent analytical checks, not warehoused by a third-party middleman.
We set our standard L-Alanine assay (measured by HPLC or titration) at not less than 98.5%, typically exceeding 99.0% on a dry basis. For most industrial and nutraceutical uses, this level ensures the compound reaches expectations for purity, minimizing contamination from other amino acids or byproducts. Food and pharma sectors both scrutinize residuals, so we monitor for loss on drying, ignited residue, and heavy metals, not just the assay figure.
On the production floor, our technicians monitor each stage of the crystalline L-Alanine process, from fermentation or chemical synthesis through to final crystallization. Consistent record-keeping allows us to verify each batch’s certificate of analysis, as well as support regulatory filings. Practical experience tells us anything under 98.5% purity leaves too much room for customer rejection or end-use problems, especially in injectable formulations and high-volume dietary applications.
We see first-hand how downstream processing and formulation stability depend on these high-purity specs. Impurities — even those below 1% — can alter how an end-user processes their product. For example, in IV solutions, a trace amount of an unwanted amino acid may trigger regulatory headaches or clinical testing failures. Our custom food clients rely on consistent crystalline material so their mixes and blends remain identical across production cycles.
We invest in monitoring systems and chromatography equipment to hold that line on purity. Raw material selection, process maintenance, pH control, and filtration techniques all receive staffing and technical oversight. Our lab releases nothing without a signed-off report and clear numeric assay, so there is no room for guesswork or ambiguity.
Most multinational and regional regulatory agencies expect assay results to be documented on a dry basis for L-Alanine, confirming the material meets or exceeds published pharmacopeial standards (such as those in the JP or USP compendia). We follow these figures not because they are minimum legal requirements but because our process allows us to hit those heights time and again. Consistency drives our approach. We back every drum and fiber carton with documentation confirming purity, moisture, and contaminant values.
We recognize global clients may request even tighter specifications. Our technical team can work directly with formulation specialists to develop custom assays, deal with specific moisture targets, or implement additional testing for niche applications. Flexibility lies in our production footprint; we make these changes on the line, not by relabeling outside product.
For us, publishing a 98.5% or higher assay is more than a marketing claim. It is a daily operational benchmark, supported by decades of experience in bulk amino acid manufacture. Customers counting on direct shipment appreciate that each load matches its certificate. We remain ready to supply full technical documentation and talk directly about how our product strength can support your next formulation or process requirement.
Among the amino acids we manufacture, L-Alanine continues to see steady demand from diverse sectors such as biopharma, food processing, and research laboratories. Since most of our production throughput is made-to-order, availability and lead times relate directly to our batch control methodology and factory logistics.
We package L-Alanine directly at our facility, keeping an eye on quality and integrity from synthesis to shipment. Our most requested bulk size is the 25-kilogram fiber drum with a double polyethylene liner to limit contamination risk and prevent caking in transit. This is the most efficient form to handle, palletize, and move through most warehouse infrastructure.
Some customers working with high-throughput downstream processes ask for intermediate bags or supersacks up to 500 kilograms each. We offer these formats for regular contracts or projects requiring larger volume, coordinating logistics with our logistics team to ensure secure transit.
Small lot requests, such as 1 kg and 5 kg sealed bags, are primarily for pilot studies or research labs. We prepare these in dedicated filling lines to meet QC stringency. Spot orders in these sizes occasionally face an extra handling fee, as our workflow focuses on container-scale output, but we maintain flexibility for scientific partners and emerging applications.
Lead times reflect our in-plant scheduling and the specific specifications required by the end user. Typical restock protocols target a 2–3 week window for standard 25 kg drums from reservation to shipment—provided demand stays within forecasted bounds. Certain seasons see extended requests from nutraceutical and pharmaceutical partners, impacting slot allocation across our reactors and drying units.
Large-scale contracts—above 5 metric tons—require coordination with raw material receiving, production queuing, and pre-shipment quality controls like chromatographic purity checks and microbial testing. This sets total lead times for these orders at 4–6 weeks, sometimes slightly more when shipping lanes experience port congestion or container shortages. We do not break contract unless faced with force majeure, but advanced planning benefits both sides. We welcome advanced forecasts or blanket orders so that we position feedstock inventory and schedule production campaigns more efficiently.
We produce all L-Alanine in accordance with GMP principles, and full batch traceability records are maintained. Our QA and regulatory team review every drum before it leaves our gate. Documentation such as certificate of analysis, mass balance and shipment trace accompanies each delivery. Requests for specialized packaging or labeling—such as export-specific requirements or client-supplied artwork—can add several days to overall processing time, as they require extra coordination among operations, printing, and warehouse staff.
Bulk L-Alanine covers a spectrum of uses, so robust communication about expected delivery dates, storage conditions, and purity requirements matters. Our team approaches every inquiry with direct accountability, aiming for prompt updates and factory-accurate responses. For repeat buyers and institutional users, we assign single-point contacts to manage ongoing logistics and field any technical questions about grade consistency or downstream compatibility.
Direct from factory to client, transparency and reliability underpin every batch. We encourage partners to outline volume needs and application timelines early so we can deliver our L-Alanine to meet their processes without delay or supply chain headaches.
Producing L-Alanine for food and pharmaceutical clients involves more than executing chemical reactions at scale. Every batch we ship carries our name and reputation, so we cannot afford shortcuts with regulatory compliance or documentation. It’s one thing to claim “food grade” or “pharma grade” quality, but meeting those standards requires diligence right from raw material intake through every stage of production, and finally in storage and transport. Food Contact Notifications, pharmacopoeial monographs, and rigorous audits are part of our regular calendar, not an afterthought.
We manufacture L-Alanine using processes and plant environments that align with relevant standards, such as FCC for food grade and EP/USP for pharmaceutical uses. Our team keeps up-to-date with amendments and official notices. Maintaining full traceability for each batch, we document sources, processing conditions, and in-process verification—all subject to routine review by customers’ QA teams and local regulators.
Inspections aren't rare events for us. Food safety authorities and pharmaceutical auditors have unrestricted access to our records and sites. Their scrutiny ensures tighter internal controls and better outcomes for customers. Our internal QA team performs routine sample analysis using validated methods—including high-performance liquid chromatography and microbial limit testing—to confirm each lot meets purity, safety, and heavy metal limits required by official compendia. Records are stored for reference throughout the product’s lifecycle and well past the minimum legal retention period.
Every delivery of our L-Alanine includes a genuine Certificate of Analysis (COA) covering quality attributes like assay, pH, loss on drying, and heavy metals. The COA also references key regulatory parameters—not as formalities, but because our own manufacturing license and export eligibility depend on proper documentation. Alongside the COA, we provide the MSDS tailored for local compliance, whether for European REACH requirements or North American specifications. This ensures downstream users and logistics partners can assess hazards and storage needs at each point in the supply chain.
Our technical support team routinely handles document requests for kosher and halal status, BSE/TSE risk statements, allergen information, and GMO declarations—each substantiated by direct records from our manufacturing process. Audit teams from multinational pharma and food firms have direct access to supplier documentation. Traceability has become a non-negotiable expectation, so our documentation process prioritizes batch-wise tracking and availability rather than just issuing generic one-page certificates.
We regularly participate in industry workshops, government consultations, and third-party audits to keep our practices ahead of new regulatory trends. Emerging topics like nitrosamine limits or changes in maximum allowable levels for process contaminants often require us to refine analytical protocols or invest in new laboratory equipment. In recent years, increased interest in low-residue and vegan manufacturing has led us to further expand documentation on animal-origin inputs and cleaning validations. Any regulatory update or customer request gets documented for continual improvement and easier future compliance reviews.
Direct collaboration between production, quality control, and technical services ensures we don’t just react to external audits or questions from clients. Our factory management sees robust compliance and open documentation as the only way to sustain long-term commercial partnerships and regulatory authorization for global supply. The outcomes are trust, reduced recall risks, and easier market access for every customer using our L-Alanine.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
